Parnika Prashasti Saxena, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Graduated 2010
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Saxena’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A139232 · Current
Licensed to practise in California · since 2015 · expires 2027-10-31 · Maharashtra University of Health Sciences, Rajiv Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Geriatric Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$103,597
Medicare paid this office $103,597 for 140 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $32,894 | $70 |
| Long return visit (40+ min) | 39 | $21,378 | $166 |
| Return visit (30+ min) | 64 | $20,721 | $120 |
| Therapy using electrical currents | 28 | $10,258 | $90 |
| Short return visit (20+ min) | 27 | $4,799 | $84 |
See all 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $32,894 | $70 |
| Long return visit (40+ min) | 39 | $21,378 | $166 |
| Return visit (30+ min) | 64 | $20,721 | $120 |
| Therapy using electrical currents | 28 | $10,258 | $90 |
| Short return visit (20+ min) | 27 | $4,799 | $84 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $4,085 | $65 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 52 | $1,453 | $15 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,282 | $107 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,043 | $74 |
Who their Medicare patients are
140 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 14% · Women 63% · Also on Medicaid 24% · Health risk score 1.47. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 67% · Dementia 35% · Coronary heart disease 29% · Diabetes 28% · Chronic kidney disease 27% · Atrial fibrillation 20% · Cancer 19% · Heart failure 14% · Stroke 12% · COPD 11%.
The office billed $541,519, Medicare allowed $133,001 and paid $103,597; for 1,181 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 140 | 1,181 | 76 | 1.47 | $541,519 | $103,597 |
| 2023 | 117 | 1,122 | 75 | 1.69 | $489,182 | $88,630 |
| 2022 | 55 | 327 | 73 | 1.56 | $136,296 | $25,990 |
| 2020 | 15 | 24 | 50 | 1.15 | $479 | $100 |
| 2019 | 21 | 23 | 51 | 1.65 | $383 | $107 |
| 2018 | 20 | 27 | 59 | 1.84 | $3,164 | $369 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $24,952 | $71 |
| Return visit (30+ min) | 55 | $22,214 | $119 |
| Long return visit (40+ min) | 32 | $12,548 | $165 |
| Therapy using electrical currents | 26 | $11,733 | $93 |
| Telehealth originating site facility fee | 71 | $5,471 | $22 |
| Short return visit (20+ min) | 30 | $3,409 | $81 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $2,009 | $63 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,409 | $74 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $9,512 | $64 |
| Long return visit (40+ min) | 18 | $6,676 | $171 |
| Return visit (30+ min) | 27 | $4,575 | $117 |
| Therapy using electrical currents | 11 | $1,701 | $94 |
| Telehealth originating site facility fee | 32 | $1,255 | $22 |
2020: 1 service
| Insertion of needle into vein for collection of blood sample | 12 | $51 | $3 |
2019: 1 service
| Insertion of needle into vein for collection of blood sample | 17 | $56 | $3 |
2018: 1 service
| Short return visit (20+ min) | 14 | $283 | $19 |
Medicaid work
$14,356 in 2022
Medicaid paid $14,356 for 182 billed services this clinician did in 2022, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 182 | $14,356 |
| 2022 | 182 | 1 | 34 | $14,356 |
| 2021 | 319 | 1 | 28 | $30,178 |
| 2020 | 96 | 1 | 15 | $7,554 |
| 2019 | 13 | 1 | 12 | $540 |
| 2018 | 102 | 1 | 30 | $4,622 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 319 | $30,178 |
2020
| Short return visit (20+ min) | 96 | $7,554 |
2019
| Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | 13 | $540 |
2018
| Short return visit (20+ min) | 102 | $4,622 |
Drugs they prescribed that Part D paid
$61,753
Pharmacies billed $61,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
565 generic and 66 brand-name prescriptions · $61,753 in drug cost · 134 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 32 | $14,109 | $441 |
| Fetzima | 16 | $13,670 | $854 |
| Quetiapine | 48 | $1,662 | $35 |
| Olanzapine | 46 | $730 | $16 |
| Sertraline | 63 | $713 | $11 |
See all 19 drugs
| Belsomra | 32 | $14,109 | $441 |
| Fetzima | 16 | $13,670 | $854 |
| Quetiapine | 48 | $1,662 | $35 |
| Olanzapine | 46 | $730 | $16 |
| Sertraline | 63 | $713 | $11 |
| Divalproex Sodium Er | 21 | $595 | $28 |
| Nortriptyline | 12 | $582 | $48 |
| Trazodone | 27 | $531 | $20 |
| Mirtazapine | 41 | $507 | $12 |
| Aripiprazole | 23 | $471 | $20 |
| Pregabalin | 17 | $442 | $26 |
| Bupropion Xl | 12 | $288 | $24 |
| Gabapentin | 23 | $284 | $12 |
| Venlafaxine Hcl Er | 23 | $231 | $10 |
| Duloxetine | 13 | $170 | $13 |
| Clonazepam | 20 | $123 | $6 |
| Propranolol | 21 | $106 | $5 |
| Escitalopram | 17 | $106 | $6 |
| Risperidone | 16 | $89 | $6 |
Year by year
| 2024 | 631 | 66 | None | 10% | $61,753 |
| 2023 | 501 | 62 | None | 3% | $15,881 |
| 2022 | 2,959 | 143 | 0% (0) | 5% | $667,197 |
| 2021 | 4,400 | 143 | 0% (0) | 5% | $826,748 |
| 2020 | 4,436 | 157 | None | 5% | $660,564 |
| 2019 | 3,063 | 180 | 0% (0) | 6% | $392,855 |
| 2018 | 1,979 | 132 | 0% (0) | 5% | $170,914 |
| 2017 | 270 | 55 | 0% (0) | None | $28,847 |
| 2016 | 649 | 48 | 0% (0) | 4% | $44,982 |
| 2015 | 705 | 33 | 0% (0) | 7% | $64,601 |
| 2014 | 273 | 35 | None | 10% | $27,685 |
| 2013 | 23 | 14 | None | None | $3,051 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Olanzapine | 62 | $1,559 | $25 |
| Bupropion Xl | 22 | $987 | $45 |
| Mirtazapine | 37 | $674 | $18 |
| Quetiapine | 25 | $594 | $24 |
| Sertraline | 39 | $520 | $13 |
| Clonazepam | 28 | $362 | $13 |
| Trazodone | 13 | $295 | $23 |
| Aripiprazole | 18 | $255 | $14 |
| Clozapine | 13 | $238 | $18 |
| Gabapentin | 14 | $227 | $16 |
| Propranolol | 25 | $220 | $9 |
| Escitalopram | 14 | $207 | $15 |
| Risperidone | 14 | $185 | $13 |
| Divalproex Sodium Er | 11 | $149 | $14 |
| Nortriptyline | 21 | $103 | $5 |
| Fluoxetine | 12 | $70 | $6 |
2022: 48 drugs
| Austedo | 44 | $402,935 | $9,158 |
| Aripiprazole | 121 | $10,714 | $89 |
| Fetzima | 14 | $6,218 | $444 |
| Quetiapine | 198 | $5,015 | $25 |
| Memantine | 60 | $4,835 | $81 |
| Olanzapine | 175 | $3,692 | $21 |
| Divalproex Sodium Er | 42 | $3,506 | $83 |
| Oxcarbazepine | 59 | $2,662 | $45 |
| Prazosin | 77 | $2,134 | $28 |
| Sertraline | 145 | $1,739 | $12 |
| Ramelteon | 20 | $1,671 | $84 |
| Bupropion Xl | 52 | $1,661 | $32 |
| Duloxetine | 60 | $1,615 | $27 |
| Trazodone | 155 | $1,558 | $10 |
| Mirtazapine | 108 | $1,492 | $14 |
| Venlafaxine Hcl Er | 91 | $1,409 | $15 |
| Loxapine | 19 | $1,324 | $70 |
| Hydroxyzine | 69 | $1,252 | $18 |
| Gabapentin | 82 | $1,216 | $15 |
| Escitalopram | 78 | $1,076 | $14 |
| Ziprasidone | 25 | $1,067 | $43 |
| Buspirone | 82 | $1,031 | $13 |
| Bupropion Hcl Sr | 35 | $933 | $27 |
| Benztropine Mesylate | 70 | $831 | $12 |
| Clonidine | 104 | $819 | $8 |
| Risperidone | 96 | $789 | $8 |
| Fluoxetine | 86 | $761 | $9 |
| Amantadine | 15 | $743 | $50 |
| Nortriptyline | 22 | $714 | $32 |
| Divalproex | 28 | $617 | $22 |
| Haloperidol | 29 | $607 | $21 |
| Lorazepam | 80 | $597 | $7 |
| Lamotrigine | 39 | $516 | $13 |
| Clonazepam | 80 | $498 | $6 |
| Donepezil | 37 | $490 | $13 |
| Lithium Carbonate Er | 36 | $470 | $13 |
| Clozapine | 14 | $415 | $30 |
| Alprazolam | 23 | $363 | $16 |
| Doxepin | 19 | $316 | $17 |
| Paroxetine | 27 | $300 | $11 |
| Citalopram Hbr | 28 | $294 | $11 |
| Guanfacine Hcl Er | 17 | $285 | $17 |
| Lithium Carbonate | 16 | $270 | $17 |
| Pramipexole Dihydrochloride | 23 | $265 | $12 |
| Metformin | 34 | $255 | $7 |
| Trihexyphenidyl | 14 | $217 | $16 |
| Propranolol | 22 | $216 | $10 |
| Topiramate | 15 | $181 | $12 |
2021: 58 drugs
| Austedo | None | 49 | $412,710 | $8,423 |
| Ingrezza | None | 18 | $116,326 | $6,463 |
| Nuplazid | Parkinson's psychosis | 13 | $43,477 | $3,344 |
| Abilify Maintena | None | 12 | $27,468 | $2,289 |
| Fetzima | None | 28 | $11,967 | $427 |
| Aripiprazole | None | 206 | $9,451 | $46 |
| Vyvanse | None | 19 | $6,341 | $334 |
| Ramelteon | None | 50 | $5,530 | $111 |
| Memantine | None | 80 | $5,291 | $66 |
| Trintellix | None | 12 | $4,967 | $414 |
| Duloxetine | None | 99 | $4,814 | $49 |
| Olanzapine | None | 241 | $4,625 | $19 |
| Divalproex Sodium Er | None | 54 | $4,536 | $84 |
| Prazosin | None | 112 | $3,880 | $35 |
| Oxcarbazepine | None | 83 | $3,543 | $43 |
| Quetiapine | None | 262 | $3,492 | $13 |
| Trazodone | None | 291 | $3,052 | $10 |
| Sertraline | None | 218 | $2,820 | $13 |
| Mirtazapine | None | 170 | $2,369 | $14 |
| Hydroxyzine | None | 146 | $1,947 | $13 |
| Venlafaxine Hcl Er | None | 103 | $1,938 | $19 |
| Loxapine | None | 26 | $1,719 | $66 |
| Fluoxetine | None | 132 | $1,706 | $13 |
| Gabapentin | None | 122 | $1,667 | $14 |
| Atomoxetine | None | 31 | $1,625 | $52 |
| Bupropion Xl | None | 65 | $1,585 | $24 |
| Risperidone | None | 152 | $1,541 | $10 |
| Divalproex | None | 47 | $1,499 | $32 |
| Buspirone | None | 117 | $1,457 | $12 |
| Haloperidol | None | 46 | $1,321 | $29 |
| Bupropion Hcl Sr | None | 69 | $1,244 | $18 |
| Clonidine | None | 143 | $1,238 | $9 |
| Escitalopram | None | 108 | $1,113 | $10 |
| Lamotrigine | None | 57 | $969 | $17 |
| Lorazepam | None | 123 | $902 | $7 |
| Ziprasidone | None | 17 | $854 | $50 |
| Chlorpromazine | None | 12 | $850 | $71 |
| Paroxetine | None | 53 | $835 | $16 |
| Benztropine Mesylate | None | 77 | $813 | $11 |
| Nortriptyline | None | 25 | $811 | $32 |
| Alprazolam | None | 42 | $804 | $19 |
| Donepezil | None | 60 | $761 | $13 |
| Clonazepam | None | 112 | $744 | $7 |
| Lithium Carbonate Er | None | 57 | $717 | $13 |
| Propranolol Hcl Er | None | 13 | $605 | $47 |
| Clozapine | None | 21 | $495 | $24 |
| Guanfacine Hcl Er | None | 24 | $469 | $20 |
| Topiramate | None | 40 | $439 | $11 |
| Doxepin | None | 24 | $426 | $18 |
| Citalopram Hbr | None | 53 | $331 | $6 |
| Lithium Carbonate | None | 24 | $327 | $14 |
| Metformin | None | 39 | $317 | $8 |
| Pramipexole Dihydrochloride | None | 24 | $301 | $13 |
| Trihexyphenidyl | None | 21 | $261 | $12 |
| Glycopyrrolate | None | 14 | $249 | $18 |
| Propranolol | None | 15 | $132 | $9 |
| Hydroxyzine Pamoate | None | 12 | $116 | $10 |
| Diazepam | None | 11 | $103 | $9 |
2020: 60 drugs
| Austedo | None | 31 | $187,582 | $6,051 |
| Ingrezza | None | 22 | $150,445 | $6,838 |
| Latuda | None | 29 | $44,750 | $1,543 |
| Nuplazid | Parkinson's psychosis | 13 | $43,807 | $3,370 |
| Abilify Maintena | None | 12 | $26,473 | $2,206 |
| Aripiprazole | None | 259 | $25,855 | $100 |
| Zoloft | None | 11 | $10,560 | $960 |
| Trintellix | None | 23 | $9,679 | $421 |
| Vyvanse | None | 25 | $8,181 | $327 |
| Belsomra | None | 12 | $5,051 | $421 |
| Prazosin | None | 122 | $4,514 | $37 |
| Divalproex Sodium Er | None | 57 | $4,504 | $79 |
| Fetzima | None | 11 | $4,477 | $407 |
| Ramelteon | None | 33 | $4,093 | $124 |
| Oxcarbazepine | None | 108 | $4,015 | $37 |
| Duloxetine | None | 93 | $3,920 | $42 |
| Olanzapine | None | 191 | $3,538 | $19 |
| Memantine | None | 82 | $3,164 | $39 |
| Quetiapine | None | 242 | $3,082 | $13 |
| Mirtazapine | None | 189 | $2,763 | $15 |
| Trazodone | None | 284 | $2,260 | $8 |
| Sertraline | None | 238 | $2,251 | $9 |
| Ziprasidone | None | 15 | $2,152 | $143 |
| Gabapentin | None | 142 | $1,902 | $13 |
| Venlafaxine Hcl Er | None | 104 | $1,710 | $16 |
| Risperidone | None | 132 | $1,604 | $12 |
| Buspirone | None | 118 | $1,587 | $13 |
| Fluoxetine | None | 122 | $1,549 | $13 |
| Atomoxetine | None | 17 | $1,493 | $88 |
| Bupropion Xl | None | 67 | $1,476 | $22 |
| Donepezil | None | 91 | $1,372 | $15 |
| Haloperidol | None | 56 | $1,360 | $24 |
| Clonidine | None | 146 | $1,319 | $9 |
| Doxepin | None | 48 | $1,290 | $27 |
| Hydroxyzine | None | 88 | $1,286 | $15 |
| Escitalopram | None | 137 | $1,268 | $9 |
| Lorazepam | None | 148 | $1,137 | $8 |
| Haloperidol Decanoate | None | 23 | $1,130 | $49 |
| Bupropion Hcl Sr | None | 56 | $954 | $17 |
| Clonazepam | None | 119 | $941 | $8 |
| Loxapine | None | 12 | $825 | $69 |
| Divalproex | None | 22 | $775 | $35 |
| Nortriptyline | None | 23 | $710 | $31 |
| Benztropine Mesylate | None | 56 | $687 | $12 |
| Lamotrigine | None | 56 | $644 | $11 |
| Paroxetine | None | 50 | $594 | $12 |
| Guanfacine Hcl Er | None | 21 | $537 | $26 |
| Perphenazine | None | 13 | $427 | $33 |
| Lithium Carbonate Er | None | 32 | $400 | $12 |
| Pramipexole Dihydrochloride | None | 24 | $367 | $15 |
| Trihexyphenidyl | None | 27 | $367 | $14 |
| Topiramate | None | 44 | $353 | $8 |
| Citalopram Hbr | None | 60 | $339 | $6 |
| Clozapine | None | 12 | $321 | $27 |
| Metformin | None | 34 | $309 | $9 |
| Lithium Carbonate | None | 20 | $236 | $12 |
| Propranolol | None | 21 | $225 | $11 |
| Alprazolam | None | 37 | $222 | $6 |
| Hydroxyzine Pamoate | None | 13 | $107 | $8 |
| Zolpidem | None | 15 | $103 | $7 |
2019: 53 drugs
| Ingrezza | 20 | $132,258 | $6,613 |
| Aripiprazole | 177 | $32,478 | $183 |
| Latuda | 20 | $31,530 | $1,576 |
| Abilify Maintena | 12 | $27,202 | $2,267 |
| Belsomra | 17 | $6,192 | $364 |
| Vyvanse | 16 | $5,125 | $320 |
| Trintellix | 12 | $4,892 | $408 |
| Divalproex Sodium Er | 41 | $3,758 | $92 |
| Oxcarbazepine | 80 | $3,146 | $39 |
| Memantine | 64 | $3,139 | $49 |
| Olanzapine | 110 | $2,940 | $27 |
| Lamotrigine Er | 15 | $2,825 | $188 |
| Quetiapine | 160 | $2,757 | $17 |
| Prazosin | 62 | $2,239 | $36 |
| Duloxetine | 50 | $2,200 | $44 |
| Fluoxetine | 121 | $1,938 | $16 |
| Buspirone | 63 | $1,889 | $30 |
| Trazodone | 187 | $1,705 | $9 |
| Ziprasidone | 14 | $1,701 | $121 |
| Gabapentin | 75 | $1,622 | $22 |
| Donepezil | 84 | $1,603 | $19 |
| Bupropion Hcl Sr | 73 | $1,589 | $22 |
| Mirtazapine | 143 | $1,579 | $11 |
| Risperidone | 91 | $1,254 | $14 |
| Venlafaxine Hcl Er | 59 | $1,237 | $21 |
| Escitalopram | 105 | $1,162 | $11 |
| Bupropion Xl | 42 | $1,143 | $27 |
| Doxepin | 47 | $1,136 | $24 |
| Sertraline | 145 | $1,055 | $7 |
| Clonidine | 116 | $880 | $8 |
| Haloperidol Decanoate | 15 | $734 | $49 |
| Fluvoxamine Maleate | 23 | $715 | $31 |
| Dextroamphetamine-Amphetamine | 17 | $713 | $42 |
| Divalproex | 15 | $695 | $46 |
| Lorazepam | 95 | $689 | $7 |
| Citalopram Hbr | 89 | $591 | $7 |
| Hydroxyzine | 21 | $588 | $28 |
| Paroxetine | 60 | $578 | $10 |
| Clonazepam | 85 | $537 | $6 |
| Haloperidol | 21 | $407 | $19 |
| Pramipexole Dihydrochloride | 25 | $367 | $15 |
| Lamotrigine | 37 | $314 | $8 |
| Propranolol | 16 | $297 | $19 |
| Zolpidem | 26 | $292 | $11 |
| Lithium Carbonate | 17 | $221 | $13 |
| Nortriptyline | 23 | $215 | $9 |
| Benztropine Mesylate | 32 | $189 | $6 |
| Lithium Carbonate Er | 17 | $187 | $11 |
| Alprazolam | 52 | $166 | $3 |
| Amitriptyline | 15 | $117 | $8 |
| Hydroxyzine Pamoate | 12 | $114 | $9 |
| Metformin | 13 | $85 | $7 |
| Topiramate | 14 | $81 | $6 |
2018: 40 drugs
| Aripiprazole | 110 | $14,239 | $129 |
| Divalproex Sodium Er | 32 | $6,208 | $194 |
| Namzaric | 13 | $4,945 | $380 |
| Ziprasidone | 15 | $2,545 | $170 |
| Quetiapine | 139 | $1,889 | $14 |
| Prazosin | 58 | $1,867 | $32 |
| Olanzapine | 44 | $1,854 | $42 |
| Mirtazapine | 114 | $1,550 | $14 |
| Duloxetine | 40 | $1,301 | $33 |
| Oxcarbazepine | 37 | $1,279 | $35 |
| Doxepin | 30 | $888 | $30 |
| Trazodone | 138 | $839 | $6 |
| Dextroamphetamine-Amphetamine | 20 | $722 | $36 |
| Sertraline | 121 | $670 | $6 |
| Buspirone | 46 | $646 | $14 |
| Venlafaxine Hcl Er | 56 | $628 | $11 |
| Bupropion Hcl Sr | 38 | $619 | $16 |
| Fluoxetine | 69 | $598 | $9 |
| Haloperidol | 18 | $488 | $27 |
| Memantine | 12 | $474 | $39 |
| Gabapentin | 45 | $454 | $10 |
| Donepezil | 32 | $438 | $14 |
| Clonidine | 84 | $437 | $5 |
| Escitalopram | 36 | $413 | $11 |
| Risperidone | 63 | $402 | $6 |
| Bupropion Xl | 16 | $399 | $25 |
| Paroxetine | 61 | $374 | $6 |
| Pramipexole Dihydrochloride | 27 | $373 | $14 |
| Fluvoxamine Maleate | 14 | $359 | $26 |
| Lamotrigine | 51 | $328 | $6 |
| Clonazepam | 63 | $246 | $4 |
| Citalopram Hbr | 43 | $238 | $6 |
| Divalproex | 19 | $229 | $12 |
| Lorazepam | 50 | $184 | $4 |
| Hydroxyzine Pamoate | 18 | $137 | $8 |
| Benztropine Mesylate | 13 | $114 | $9 |
| Zolpidem | 14 | $114 | $8 |
| Lithium Carbonate Er | 13 | $97 | $7 |
| Alprazolam | 22 | $83 | $4 |
| Topiramate | 12 | $80 | $7 |
2017: 8 drugs
| Aripiprazole | 16 | $5,132 | $321 |
| Quetiapine | 29 | $181 | $6 |
| Trazodone | 21 | $114 | $5 |
| Venlafaxine Hcl Er | 12 | $112 | $9 |
| Sertraline | 13 | $80 | $6 |
| Lamotrigine | 13 | $72 | $6 |
| Clonazepam | 12 | $42 | $4 |
| Lorazepam | 17 | $41 | $2 |
2016: 20 drugs
| Aripiprazole | 37 | $14,312 | $387 |
| Duloxetine | 26 | $2,082 | $80 |
| Divalproex Sodium Er | 16 | $1,961 | $123 |
| Quetiapine | 37 | $1,173 | $32 |
| Divalproex | 13 | $719 | $55 |
| Trazodone | 45 | $707 | $16 |
| Mirtazapine | 11 | $415 | $38 |
| Clonazepam | 64 | $351 | $5 |
| Gabapentin | 13 | $336 | $26 |
| Oxcarbazepine | 11 | $310 | $28 |
| Risperidone | 31 | $282 | $9 |
| Olanzapine | 29 | $265 | $9 |
| Benztropine Mesylate | 32 | $238 | $7 |
| Lamotrigine | 15 | $143 | $10 |
| Fluoxetine | 15 | $101 | $7 |
| Sertraline | 24 | $81 | $3 |
| Clonidine | 15 | $65 | $4 |
| Imipramine | 13 | $46 | $4 |
| Hydroxyzine | 12 | $32 | $3 |
| Lorazepam | 13 | $16 | $1 |
2015: 26 drugs
| Abilify Maintena | 12 | $16,940 | $1,412 |
| Abilify | 14 | $15,137 | $1,081 |
| Divalproex Sodium Er | 11 | $2,709 | $246 |
| Duloxetine | 20 | $2,570 | $128 |
| Clozapine | 24 | $2,019 | $84 |
| Dextroamphetamine-Amphetamine | 13 | $1,212 | $93 |
| Mirtazapine | 15 | $668 | $45 |
| Gabapentin | 19 | $650 | $34 |
| Risperidone | 36 | $604 | $17 |
| Divalproex | 14 | $587 | $42 |
| Olanzapine | 44 | $522 | $12 |
| Quetiapine | 30 | $506 | $17 |
| Haloperidol | 12 | $405 | $34 |
| Benztropine Mesylate | 45 | $373 | $8 |
| Lithium Carbonate Er | 13 | $274 | $21 |
| Clonazepam | 73 | $271 | $4 |
| Fluoxetine | 25 | $255 | $10 |
| Trazodone | 39 | $238 | $6 |
| Fluvoxamine Maleate | 11 | $229 | $21 |
| Hydroxyzine | 13 | $191 | $15 |
| Lamotrigine | 26 | $140 | $5 |
| Sertraline | 39 | $137 | $4 |
| Clonidine | 13 | $78 | $6 |
| Prazosin | 12 | $67 | $6 |
| Lorazepam | 21 | $65 | $3 |
| Zolpidem | 12 | $26 | $2 |
2014: 6 drugs
| Olanzapine | 14 | $1,333 | $95 |
| Quetiapine | 15 | $652 | $43 |
| Risperidone | 15 | $157 | $10 |
| Benztropine Mesylate | 17 | $128 | $8 |
| Clonazepam | 27 | $123 | $5 |
| Lorazepam | 19 | $80 | $4 |
Money from drug and device companies
$84 in 2022
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | None | $84 | 1 payment
|
See the published payment
| Teva Pharmaceuticals USA | Education · 2022-06-28 | None | $84 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033464177
- Licence
- CA A139232California A139232: Current · expires 2027-10-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0805X (2084P0805X); Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-07-15
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 63 Main St, Brockton, MA, 02301